NeuroPace (NPCE) Liabilities and Shareholders Equity (2020 - 2026)

NeuroPace's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $98.9 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 10.26% year-over-year to $98.9 million in Q1 2026; TTM through Mar 2026 was $417.8 million, a 5.63% increase from a year earlier, with the FY2025 full-year figure at $105.6 million, up 11.54% from the prior year.
• Liabilities and Shareholders Equity declined to $98.9 million in Q1 2026 per NPCE's latest filing, from $105.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $129.0 million in Q1 2022 and bottomed at $94.4 million in Q2 2024.
• The 5-year median for Liabilities and Shareholders Equity is $106.1 million (2025), against an average of $106.5 million.
• Biggest YoY gain for Liabilities and Shareholders Equity was 156.3% in 2022; the steepest drop was 19.34% in 2022.
• Year by year, Liabilities and Shareholders Equity stood at $114.1 million in 2022, then slipped by 5.66% to $107.7 million in 2023, then fell by 12.08% to $94.6 million in 2024, then increased by 11.54% to $105.6 million in 2025, then declined by 6.32% to $98.9 million in 2026.
• Per Business Quant, the three latest NPCE Liabilities and Shareholders Equity figures stand at $98.9 million (Q1 2026), $105.6 million (Q4 2025), and $107.3 million (Q3 2025).